Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Altamira Therapeutics Ltd
(NQ:
CYTO
)
0.9553
-0.0291 (-2.96%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Altamira Therapeutics Ltd
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 20, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
November 17, 2023
Via
Benzinga
Why Is Altamira Therapeutics (CYTO) Stock Up 160% Today?
November 17, 2023
CYTO stock shares have absolutely skyrocketed today, at one point more than tripling on heavy volume on a key bullish catalyst.
Via
InvestorPlace
S&P 500 Edges Higher; Buckle Shares Surge After Q3 Earnings
November 17, 2023
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow traded up 0.07% to 34,969.63 while the NASDAQ rose 0.21% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 17, 2023
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via
Benzinga
Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales
November 17, 2023
U.S. stocks traded mostly flat midway through trading on Friday. The Dow traded up 0.01% to 34,945.78 while the NASDAQ fell 0.03% to 14,109.53. The S&P 500 also rose, gaining, 0.05% to 4,510.71.
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Allergy-Focused Altamira Therapeutics Stock Trading Over 200% Higher Today?
November 17, 2023
Altamira Therapeutics Ltd (NASDAQ: CYTO) entered into a binding agreement to sell a 51% stake in its subsidiary Altamira Medica AG to a Swiss private equity investor as part of its strategic...
Via
Benzinga
US Stocks Edge Lower; Housing Starts Rise In October
November 17, 2023
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite falling around 30 points on Friday. Following the market opening Friday, the Dow traded down 0.04% to 34,931.47 while the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
November 17, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine
November 10, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 06, 2023
Via
Benzinga
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Via
Benzinga
Why Is Fortinet (FTNT) Stock Down 22% Today?
November 03, 2023
Fortinet stock is dropping on Friday as investors in FTNT lament the company's revenue outlook included in its latest earnings report.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
Why Is Bill Holdings (BILL) Stock Down 29% Today?
November 03, 2023
Bill stock is falling on Friday as investors in the company react to its lackluster guidance in its fiscal Q1 2024 earnings report.
Via
InvestorPlace
Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
November 03, 2023
Gainers Altamira Therapeutics Ltd (NASDAQ: CYTO) shares surged 54.1% to $0.25 in pre-market trading after gaining 5% on Thursday.
Via
Benzinga
Why Is Innovative International (IOAC) Stock Up 9% Today?
November 03, 2023
Innovative International stock is rising on Friday with heavy trading of IOAC shares following results from a shareholder meeting.
Via
InvestorPlace
Why Is Altamira Therapeutics (CYTO) Stock Up 28% Today?
November 03, 2023
Altamira Therapeutics stock is rising higher on Friday with heavy trading of CYTO shares despite a lack of news from the company.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 03, 2023
It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!
Via
InvestorPlace
RNA Therapies Hold The Power To Transform Treatment For Numerous Ailments, But Delivering These Remains Problematic – Will This Biotech Change That?
September 19, 2023
Thomas Meyer, CEO of Altamira Therapeutics (NASDAQ: CYTO), was recently a guest on Benzinga’s All-Access.
Via
Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
September 15, 2023
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 15, 2023
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
September 14, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
September 12, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Earnings Scheduled For September 12, 2023
September 12, 2023
Companies Reporting Before The Bell • Root (NASDAQ:ROOT) is projected to report quarterly loss at $0.10 per share on revenue of $48.95 million.
Via
Benzinga
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
September 06, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.